Overexpression of DNMT3B is related to drug resistance [33, 34] and the mTORC1 pathway is known to play an important role in the pathogenesis of lymphoma and various type of cancer [35], suggesting that these mechanisms may contribute to PDX resistance. Here, DNMT3B is linked to cancer.